Award winning executive search to the private, and investor backed health, care, and life sciences sectors

Health Tech Round Table: A discussion around the challenges and opportunities within HealthTech domestically and globally

Trusted executive search partner to the investment community delivering outstanding leaders for the healthcare and life sciences sectors

Mandates delivered to date

0 %

Delivery rate of all retained mandates

0 %

C-suite appointments are women

0 +

Sub-sectors in healthcare and life sciences supported

Healthcare news, data and analysis
Via Investors in Healthcare

BC Partners, a European investment firm, has entered into exclusive negotiations with France-headquartered Servier, an international pharmaceutical company, for the acquisition of Biogaran, one of France’s largest generic drug companies. […]

France: Servier and BC Partners open negotiations for the sale of Biogaran

July 30, 2025

Buy Out M&A Manufacturing – Generics News Pharma

Belgium-founded contract manufacturer Aminolabs Nutrition has acquired Spain-based Zoka Pharma, a producer of nutritional supplements. With Zoka, Aminolabs gets a robust product portfolio and enhanced production infrastructure, enabling the group […]

Spain: Aminolabs Nutrition expands European footprint with acquisition of Zoka Pharma

July 30, 2025

Animal Health Consumer Healthcare Healthcare M&A News

The European healthcare M&A landscape is undergoing a structural shift. From rapid exits and pre-emptive deals to a growing appetite for complex, platform-building strategies and the rising importance of technology […]

Healthcare M&A adapts to a world of uncertainty, complexity—and tech-driven growth

July 29, 2025

Analysis Healthcare Life Sciences Pharma Europe

Tractive, the Austria-headquartered global provider of health monitoring and GPS tracking for dogs and cats, has acquired Whistle, the connected pet wearable brand owned by Mars Petcare. The deal adds Whistle’s customer […]

Austria: Tractive strengthens US pawprint with acquisition of Whistle from Mars

July 29, 2025

Animal Health M&A News Veterinary Austria

Beyond Capital Partners, a mid-market investment company focused on the DACH region, has acquired 100% of the shares in Germany-based KLmed. KLmed specializes in the provision of highly qualified professionals […]

Germany: Beyond Capital Partners acquires KLmed to support agency’s growth plans

July 29, 2025

Buy Out Healthcare M&A News Staffing

Tiger Infrastructure Partners, a middle-market private equity firm investing in new and growing infrastructure platforms, has acquired EMED Group, a UK specialist healthcare transport provider, from Cairngorm Capital, a specialist […]

UK: EMED has been acquired by Tiger Infrastructure Partners

July 29, 2025

Buy Out Healthcare M&A News Craig Smith

Triquera, the holding company of Minapharm Pharmaceuticals and Chemical Industries (Minapharm), an Egypt-based biopharmaceutical company and CDMO, has raised capital via a minority stake investment from Rwanda-based Admaius Capital Partners […]

Egypt: Minapharm majority shareholder Triquera gains investment from Admaius Capital Partners

July 28, 2025

News Pharma Services – CRO/CMO/CDMO Venture Admaius

ASX-listed Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company, has completed a A$203m (US$132m) placement to institutional investors. The offer price per new fully paid ordinary share was A$4.20, representing a 2.2% […]

Australia: Clarity completes A$203m institutional placement

July 28, 2025

News Pharma Public Equity Alan Taylor Australia

MedComms Experts (MCE), a global medical communications agency with offices in the US and Switzerland backed by US-based investment firm The Brydon Group, has acquired NexGen Healthcare Communications, a UK-headquartered […]

UK: MedComms Experts scales with acquisition of NexGen Healthcare Comms

July 28, 2025

Buy Out M&A News Pharma Services – Medical Communications

Nasdaq-Stockholm listed Loomis, a Swedish cash handling company, through its subsidiary Loomis International Corporate, is acquiring Kipfer-Logistik a Switzerland-based logistics company specializing in temperature-controlled transport and storage in the pharmaceutical […]

Switzerland: Loomis expands pharma business with acquisition of Kipfer-Logistik

July 28, 2025

M&A News Pharma Services – CRO/CMO/CDMO Aritz Larrea

Healthcare Holding Schweiz, through its subsidiary Mikrona Group, has completed the acquisition of Switzerland-based FTC Frey Trading & Consulting and the associated online training platform MyDentalExpert. Founder Bernhard Frey will […]

Switzerland: Mikrona completes acquisition of FTC Frey Trading & Consulting

July 25, 2025

Buy Out Dental Healthcare Life Sciences M&A

Ardian, a global private investment firm, has acquired a majority stake in Horizon Home Care Group, a Swiss-based international provider of non-medical home care services operating under the name Dovida. […]

Switzerland: Ardian to support future growth strategy of international home care provider Dovida

July 24, 2025

Buy Out Homecare M&A News Social Care

Five Arrows, the alternative assets arm of Rothschild & Co, as made a strategic investment in Hublo, a France-based provider of digital HR solutions for the healthcare sector. Hublo helps healthcare […]

France: Five Arrows makes strategic investment in Hublo

July 24, 2025

Digital Health/Healthtech Healthcare News Venture Five Arrows

IK Partners, a European private equity firm focused on investments in the Benelux, DACH, France, Nordics and the UK, has closed its fourth Small Cap fund, the IK Small Cap […]

Europe: IK Partners raises €2.0bn for fourth Small Cap fund

July 24, 2025

Healthcare News Venture Christopher Masek Europe

Australasia life sciences venture capital firm, Brandon Capital, has announced the final close of its sixth fund at A$439m (US$290m). Brandon BioCatalyst Fund Six (BB6) was launched in 2024 with […]

Australia: Brandon Capital holds final close of Fund Six at A$439m

July 24, 2025

Life Sciences News Pharma Venture Australia

NUS Enterprise, the entrepreneurial arm of the National University of Singapore (NUS), is committing S$150m (US$116m) to launch the NUS VC Programme to boost growth of deep tech start-ups. The […]

Singapore: NUS commits S$150m in VC programme to boost growth of deep tech start-ups

July 23, 2025

Life Sciences News Pharma Venture 4BIO Capital

UBS has expanded its Global Banking Healthcare team with the addition of three managing directors specializing in biotechnology, further strengthening our Healthcare franchise. Noël Brown joins as head of Biotechnology […]

US: UBS strengthens global banking healthcare team with three biotech hires from RBC

July 23, 2025

News People Pharma Alex Lim Noël Brown

Norwegian PE firm Longship has acquired a majority stake in Nordiclabs (NordicNeuroLab), a Norwegian medical technology company. The investment represents a new platform acquisition – the fifth – for Longship […]

Norway: Longship completes acquisition of majority stake in NordicNeuroLab

July 22, 2025

Buy Out Life Sciences M&A Medtech – Hospital Equipment News

UK-headquartered Vicebio, a biopharmaceutical company developing novel vaccines against life-threatening respiratory viral infections, is being acquired by France-based global biopharma Sanofi. Shareholders will receive up to a total of US$1.6bn, […]

UK: Sanofi to acquire next-generation vaccine biotech Vicebio for US$1.6bn

July 22, 2025

Buy Out M&A Manufacturing – Specialty Pharma News Pharma

EQT is set to acquire a majority stake in Malta-based global pharmaceutical company Adalvo from Iceland-based healthcare private equity investor Aztiq led by Robert Wessman. “Having EQT by our side […]

Malta: EQT agrees to acquire Adalvo from Aztiq to drive next growth phase

July 22, 2025

Buy Out M&A Manufacturing – Generics News Pharma

Palamon Capital Partners, a UK-based pan-European growth investor, has announced the sale of its majority stake in mydentist, the UK’s largest provider of affordable dentistry, to funds managed by Bridgepoint […]

UK: Palamon sells its majority stake in mydentist to Bridgepoint

July 21, 2025

Buy Out Dental Healthcare M&A News

Canada-based Ontario Teachers’ Pension Plan Board (Ontario Teachers’) is to acquire Donte Group alongside its management team today from US PE firm, Advent International, in a deal that values the […]

Spain: Ontario Teachers’ agrees acquisition of Donte Group from Advent

July 21, 2025

Buy Out Dental Healthcare M&A News

Ampersand Capital Partners, a private equity life sciences and healthcare growth investor, has acquired CurTec Group, a Netherlands-based manufacturer of plastic packaging solutions for pharmaceutical and specialty chemical applications from […]

Netherlands: Ampersand Capital Partners acquires CurTec from Bencis

July 21, 2025

Buy Out M&A News Pharma Services – CRO/CMO/CDMO

Compagnie Nationale à Portefeuille (CNP), a Belgium-based private investment company originally founded by Albert Frère, is acquiring Equine Care Group (ECG) from Dutch PE firm Bencis to support the veterinary […]

Belgium: CNP to acquire Equine Care Group from Bencis

July 21, 2025

Buy Out M&A News Veterinary Veterinary Clinics

Numan, a UK leader in preventative digital healthcare, has raised US$60m in fresh funding, led by Greece-based Big Pi Ventures, a multi-stage equity investor in technology businesses. The fundraise also […]

UK: Numan raises US$60m in fresh funding

July 19, 2025

Articles Digital Health/Healthtech Healthcare News Venture

Our Sectors

We are experts at what we do

Healthcare

Social Care

Biopharmaceuticals

Medical Technologies

Enabling Services

01 Our People

A dedicated team of executive search experts, delivering for you

The Compass Carter Osborne team are healthcare and life science experts. As a trusted advisor we bring decades of search experience and an unparalleled track record of delivery across our dedicated sectors for our investor clients – relied upon time and again to build outstanding leadership teams.

Familiar faces at key industry events, our expertise extends beyond the mere placing of people with our consultants bringing together sector leaders to address key challenges, working in partnership to produce tangible solutions.

Our Team

Meet the Team

Adam Carter

Meet the Team

Luke Osborne

Meet the Team

Abigail Badà

Meet the Team

Sam Leighton-Smith BA Hons

02 Expertise

Unearthing rare talent, that drive successful exits

Responsive, adaptable, and emotionally intelligent, Compass Carter Osborne avoid the one-size-fits-all approach to ensure our clients achieve their desired outcome by presenting a broad range of intuitive, tailored solutions, based on specific needs.

Expertise

Board

Expertise

Executive Leadership

Expertise

Finance & Commercial

Expertise

People & Culture

03 Our Approach

Tailoring our offering,
to provide a bespoke service

Results driven, not process led, CCO avoid the conformity of a rigid process. Never assumptive, we listen and adopt an agreed approach which most closely delivers to a clients specific needs. Understanding the uniqueness of each role, our people tailor a search to bespoke requirements to ensure solutions that delivers the best possible results first time, every time.

Our Approach

A trusted advisor to the investment community
providing leaders advancing the healthcare and life sciences sectors

What our clients say

“Compass Carter Osborne really delivered for us in our search for a new CEO for Outcomes First Group. It was a vitally important assignment given that we were recruiting a successor for a long standing and highly successful CEO in a sector-leading business. Compass Carter Osborne went above and beyond in developing a deep understanding of the business and our requirements, and in only presenting candidates that closely met these. They think very creatively and their focus was very sharp; they particularly understood the culture of the business. The search was speedy and well organised, with a very high standard of verbal and written feedback. They have a granular knowledge of the sector and because of the way in which they work, we were fully involved throughout and achieved a great result. A really excellent search – thank you.”

Outcomes First Group – Chair

“Compass Carter Osborne started from the very beginning with a detailed, professional explanation of the available position. They spent time to present the great opportunity and chance to accelerate my career but at the same time, the challenge, and the strong expectation from their client.”

Hengrui Therapeutics – VP, Head Biological Drug Discovery

“Compass Carter Osborne delivered on a key appointment for the PFA and the wider football industry. It was a complex brief involving creating an entirely new position. The role was vitally important, with the successful candidate taking on a sensitive and multifaceted responsibility across CTE, concussion and brain health in professional football. CCO led a comprehensive and exhaustive process, developing a deep understanding of the union’s requirements and using his expert knowledge to help scope and evolve the brief throughout the search. The entire process was professional, efficient and well organised, with consistent communication and feedback at every stage.”

The Professional Footballers Association (PFA) – Chief Executive Officer

“I have been so impressed by Luke’s integrity, clear purpose and drive to achieve for his clients. Luke has worked with Priory on a number of things but more recently to source two independent Non Executive Directors and a Director of Talent Acquisition. He has kept us informed, fielded some great candidates and follows up at each stage, even when they have started. I would really recommend him if you are searching for high calibre individuals.”

Priory Group – Chief Executive Officer

“I recently had the pleasure of being appointed to an independent healthcare provider as a NED after being put forward for the role by Luke. Throughout the whole recruitment process I was treated with respect and felt valued. I was particularly impressed with the follow up support after the decision to appoint me, which I have never experienced from other search companies. Luke continued to check in with me to ensure my onboarding went smoothly and that I had settled into the role. Overall, a highly professional and comprehensive approach delivered personally by Luke.”

Priory – Independent Non-Executive Director

“Luke was absolutely brilliant along the journey. He acted as a real partner and was able to answer to all my questions in order to get comfortable with the decision of making the change. His expertise and knowledge of the sector really came out along the process. Most importantly, he was always available when I needed him to be, which is something I valued a lot. In summary, I couldn’t recommend him and Compass Carter Osborne enough.”

AniCura – Group Chief Operating Officer

“We worked with Compass Carter Osborne in the search for our Chief Financial Officer and from the start it was clear they were a good choice of partner. A focus on understanding our needs as a business, and mine personally as a CEO were front of mind for Paul and Kieran. They took the time to listen, understand and not only focus on the functional aspects of the role – but critically, the team fit and culture we are building. Process, structure and follow-through were like clockwork, and the quality of candidates were of a consistently high-level. I would highly recommend Compass Carter Osborne.”

Renaiss Health – Chief Executive Officer

“I’ve known Tarquin for over 15 years, during which time he has delivered a number of executive assignments at senior level, including COO/executive team and senior management roles in scientific/professional disciplines (his network in the biotech/life-sciences sector is second-to-none!). He works hard to truly understand both the candidate brief and the culture of the company, sets realistic expectations and retains regular contact as an assignment progresses, always providing thorough updates and pragmatic advice. He has the highest levels of professionalism and integrity – he really is a pleasure to work with.”

One Nucleus – Director

“Jamie did a great job – he really took the time to understand our business, our needs and what we were looking for. We knew our brief was specific, yet Jamie met all our expectations with the search. He maintained a high standard of communication and meticulous attention to detail throughout the process. I would recommend Jamie and the Compass Carter Osborne team without hesitation.”

Melrose Education – Chair & CEO

“Our recent work with Compass Carter Osborne was exceptional. The search was perfectly organised, response times were swift, and due to the consultant market knowledge and network, we quickly found our ideal candidate.”

Schoen Clinic – Member of Group Executive